ASU

Preferred Sample Type

Alpha Subunits (ASU)

Suitable Specimen Types

Serum

Alpha Subunits (ASU) ASU

Specimen Volume

1 mL blood (min 500uL serum)

Specimen Transport

First Class Post

Sample Preparation

Centrifuge and separate serum and store at -20°C

Turnaround Time

3 weeks

Sample Processing In Laboratory

No special requirements

Sample Stability

5 days at 4°C or 6 months at -20°C

General Information

TSH, LH and FSH are glycoproteins composed of two sub-units termed α and β. The intact glycoproteins and their common α sub-unit (ASU) are secreted in a pulsatile manner in normal subjects. The majority of pituitary adenomas produce pathological symptoms resulting from hypersecretion of the hormone by a tumour. However, up to 30% of such tumours have no such pathology and have been termed clinically non-functioning. It has been reported that a large number of such non-functioning adenomas may synthesise and secrete intact glycoprotein hormones or their sub-units.

Serum ASU may also be elevated in patients with functioning pituitary tumours such as the rare thyrotropinmas and gonadotropinomas. Measurement of ASU may be used for the detection and monitoring of these adenomas.

It may also be elevated in primary hypogonadism, renal failure and primary thyroid disease and interpretation of the results should take these factors into account.

ASU may be elevated in gastro-entero-pancreatic tumours and in particular it may be useful in the investigation of anomalous thyroid function tests, where thyrotropinoma, thyroid hormone resistance and analytical interference have all to be considered.

Patient Preparation

No special patient preparation required. Sample must be collected into yellow or red top container only.

Notes

Please send clinical details including results of other pituitary hormone tests.

Reference Range

  • Adult males and pre-menopausal females: <1.0 IU/L
  • Post-menopausal or mid-cycle females: <3.0 IU/L

Pregnancy - there is a 0.1% cross reaction with hCG resulting in very high ASU results in pregnancy.

Results should be interpreted along with the serum LH, FSH and TSH results and renal function tests.

Source of Reference Range

In house validation

Specifications

  • EQA Status:

    No EQA Scheme - sample exchange in place

  • EQAS Scheme: No

General Information

General information about the website and its content

Location of Laboratories

Where the laboratories are located and information about the services offered at each laboratory